𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lipoconjugates for the Noncovalent Generation of Microarrays in Biochemical and Cellular Assays

✍ Scribed by Antje Hoff; Thomas André; Tilman E. Schäffer; Günther Jung; Karl-Heinz Wiesmüller; Roland Brock


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
439 KB
Volume
3
Category
Article
ISSN
1439-4227

No coin nor oath required. For personal study only.

✦ Synopsis


The generation of microarrays by functionalization of hydrophobic glass surfaces with conjugates of triacylated lipophilic end-groups and with a peptide or hapten as a test substance is presented. Immobilization on the hydrophobic surfaces through the triacylated anchor group is fully orthogonal to the reactivity of functional groups within the test substances. The technique is therefore free of risk that reactions of these functional groups may influence the biological activity of the test compounds in screening applications. In addition, no preactivation of either the surface or the compounds is required. Reagents and substrates may be stored at ambient conditions for long periods of time. The lipoconjugates are administered from aqueous solution enabling automated nanopipetting down to spot dimensions of 100 microm across. The microstructures are stable with respect to the conditions of biochemical assays and applications in cell biology. Due to the hydrophobicity of the nonfunctionalized surfaces, standard blocking protocols used in microtiter-plate testing can be employed, thereby inhibiting nonspecific binding of assay reagents. Generation of these microstructures on hydrophobic glass slides or coverslips enables highly sensitive multichannel read-outs with high-resolution fluorescence microscopy.


📜 SIMILAR VOLUMES


Blood-based reverse transcriptase polyme
✍ Alexandre de la Taille; Carl A. Olsson; Ralph Buttyan; Mitchell C. Benson; Emili 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB 👁 2 views

## Reverse transcriptase polymerase chain reaction (RT-PCR) assay is a sensitive technique to detect circulating cells expressing prostate-specific antigen (PSA) in blood or bone marrow from patients with prostate cancer. When applied to prostate cancer patients at our institution, this technique